🇺🇸 FDA
Pipeline program

ONDANSETRON , APREPITANT , PALONOSETRON, COMBINATIONS, PALONOSETRON , Lagipra, GRANISETRON , DEXAMETHASONE , 0.9% sodium chloride

J2R-MC-YAAD

Phase 2 small_molecule active

Quick answer

ONDANSETRON , APREPITANT , PALONOSETRON, COMBINATIONS, PALONOSETRON , Lagipra, GRANISETRON , DEXAMETHASONE , 0.9% sodium chloride for Nausea, Drug-Related Side Effects and Adverse Reactions, Vomiting, Neoplasms is a Phase 2 program (small_molecule) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).

Program details

Company
Eli Lilly Co.
Indication
Nausea, Drug-Related Side Effects and Adverse Reactions, Vomiting, Neoplasms
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials